Abstract | BACKGROUND: METHODS: Microorganisms, their ciprofloxacin resistance, and clinical outcomes were retrospectively analyzed in 78 CD patients with intra-abdominal abscesses, who underwent percutaneous drainage between March 1991, and November 2011. RESULTS: The median time from diagnosis of CD to abscess drainage was 59.5 months (range, 1 to 178 mo). As for bacteriology, the no-growth proportion was 38.5% ( n=30), and 69 microorganisms belonging to 11 genera were isolated from the other 48 (61.5%) patients. Of the 69 microorganisms, 65 were bacteria, including 30 (43.4%) gram-positive, 28 (40.6%) gram-negative aerobes, 7 (10.1%) gram-negative anaerobes, and 4 (4.1%) fungi. Streptococci spp. (25, 36.2%) were the most common bacteria, followed by Escherichia coli (18, 26.1%). Nineteen of the 28 gram-negative aerobes (67.9%) were resistant to ciprofloxacin, including 14 of 18 (77.8%) E. coli isolates. When we compared clinical characteristics and treatment outcomes in 17 patients with ciprofloxacin-resistant and 8 with ciprofloxacin-sensitive bacteria, we found that disease duration from diagnosis to drainage (97.2 vs. 50.7 mo, P=0.03) and median length of hospitalization (40 vs. 31 d, P=0.03) was significantly longer in the former. CONCLUSIONS:
|
Authors | Soo-Kyung Park, Kyung-Jo Kim, Sang-Oh Lee, Dong-Hoon Yang, Kee Wook Jung, Byong Duk Ye, Jeong-Sik Byeon, Seung-Jae Myung, Suk-Kyun Yang, Jin-Ho Kim, Chang Sik Yu |
Journal | Journal of clinical gastroenterology
(J Clin Gastroenterol)
Vol. 48
Issue 8
Pg. 703-7
(Sep 2014)
ISSN: 1539-2031 [Electronic] United States |
PMID | 24296421
(Publication Type: Journal Article)
|
Chemical References |
- Anti-Bacterial Agents
- Ciprofloxacin
|
Topics |
- Abdominal Abscess
(drug therapy, etiology, microbiology)
- Adolescent
- Adult
- Anti-Bacterial Agents
(pharmacology, therapeutic use)
- Ciprofloxacin
(pharmacology, therapeutic use)
- Crohn Disease
(complications, drug therapy)
- Drainage
(methods)
- Drug Resistance, Bacterial
- Female
- Hospitalization
(statistics & numerical data)
- Humans
- Length of Stay
- Male
- Middle Aged
- Retrospective Studies
- Treatment Outcome
- Young Adult
|